НовостиBenzingaCanaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30 Canaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30 Benzinga 2026.10.19 13:01 (GMT+0) Открыть на Benzinga Другие новости